338 related articles for article (PubMed ID: 18383462)
21. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
22. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
[TBL] [Abstract][Full Text] [Related]
23. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation.
Hsu JJ; Hsieh CC; Chiang CH; Lo LM; Hsieh TT
Chang Gung Med J; 2003 Jan; 26(1):12-9. PubMed ID: 12656304
[TBL] [Abstract][Full Text] [Related]
24. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
[TBL] [Abstract][Full Text] [Related]
25. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
[TBL] [Abstract][Full Text] [Related]
26. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K; Bindra R; Nix AB; Heath V; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):142-8. PubMed ID: 12905507
[TBL] [Abstract][Full Text] [Related]
27. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
28. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
Nicolaides KH; Brizot ML; Snijders RJ
Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
[TBL] [Abstract][Full Text] [Related]
29. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
[TBL] [Abstract][Full Text] [Related]
30. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
32. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training.
Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Ombelet WU; Nijhuis JG
J Med Screen; 2006; 13(1):4-7. PubMed ID: 16569298
[TBL] [Abstract][Full Text] [Related]
33. [Fetal nuchal translucency thickness and risk for chromosomal defects].
Nicolaides KH; Wegrzyn P
Ginekol Pol; 2005 Apr; 76(4):257-63. PubMed ID: 16013176
[TBL] [Abstract][Full Text] [Related]
34. Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21.
Kagan KO; Hoopmann M; Baker A; Huebner M; Abele H; Wright D
Ultrasound Obstet Gynecol; 2012 Aug; 40(2):135-9. PubMed ID: 22262465
[TBL] [Abstract][Full Text] [Related]
35. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness.
Vandecruys H; Faiola S; Auer M; Sebire N; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):551-3. PubMed ID: 15880648
[TBL] [Abstract][Full Text] [Related]
36. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
37. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP; Snijders RJ; Johnson SP; De Lourdes Brizot M; Nicolaides KH
Br J Obstet Gynaecol; 1995 Dec; 102(12):957-62. PubMed ID: 8652486
[TBL] [Abstract][Full Text] [Related]
38. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
39. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
[TBL] [Abstract][Full Text] [Related]
40. Nuchal translucency measurement at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
Prenat Diagn; 2005 May; 25(5):411-6. PubMed ID: 15906410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]